**Core Concept**
Disulfiram and acamprosate are medications used in the management of alcohol use disorder (AUD). Disulfiram works by inhibiting aldehyde dehydrogenase, leading to an accumulation of acetaldehyde, a toxic metabolite of ethanol. Acamprosate, on the other hand, modulates glutamate and GABA neurotransmission, reducing cravings for alcohol.

**Why the Correct Answer is Right**
The use of disulfiram and acamprosate is based on their distinct mechanisms of action. Disulfiram's efficacy relies on its ability to inhibit aldehyde dehydrogenase, an enzyme crucial for the breakdown of acetaldehyde. This inhibition leads to an unpleasant reaction when alcohol is consumed, thereby discouraging further drinking. Acamprosate, by modulating glutamate and GABA receptors, helps to reduce the craving for alcohol and supports abstinence.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because disulfiram and acamprosate are not primarily used for opioid use disorder treatment. While medications like methadone and buprenorphine are used for opioid addiction, disulfiram and acamprosate target AUD specifically.
**Option B:** This option is incorrect because disulfiram and acamprosate are not used for the treatment of depression. Although alcohol use disorder often co-occurs with depression, disulfiram and acamprosate are not antidepressants.

**Clinical Pearl / High-Yield Fact**
When initiating disulfiram therapy, it is crucial to ensure the patient understands the importance of avoiding alcohol consumption, as the medication's effectiveness relies on this principle. A baseline liver function test and regular monitoring of liver enzymes are recommended to minimize the risk of hepatotoxicity.

**Correct Answer:** C.